Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
RTX Corp
RTX
|
$1.29B |
| 2 |
Comcast
CMCSA
|
$1.19B |
| 3 |
Hilton Worldwide
HLT
|
$967M |
| 4 |
Home Depot
HD
|
$876M |
| 5 |
PayPal
PYPL
|
$849M |
Top Sells
| 1 |
AbbVie
ABBV
|
$2.85B |
| 2 |
Intel
INTC
|
$1.82B |
| 3 |
UnitedHealth
UNH
|
$1.76B |
| 4 |
Fidelity National Information Services
FIS
|
$1.48B |
| 5 |
Abbott
ABT
|
$1.41B |
Sector Composition
| 1 | Healthcare | 20.99% |
| 2 | Technology | 17.56% |
| 3 | Communication Services | 15.03% |
| 4 | Consumer Discretionary | 12.64% |
| 5 | Industrials | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Hormel Foods
HRL
$14B
| $389M | 0.15% | 8,332,806 -5,843,804 | -41% | -$273M |
|
127
Qorvo
QRVO
$8.4B
| $386M | 0.15% | 4,792,119 -2,355,136 | -33% | -$190M |
|
128
Sarepta Therapeutics
SRPT
$1.78B
| $379M | 0.15% | 3,874,958 +1,465,905 | +61% | +$143M |
|
129
Bank of Montreal
BMO
$86.7B
| $378M | 0.15% | 7,483,144 +1,877,206 | +33% | +$94.8M |
|
130
VICI Properties
VICI
$36B
| $371M | 0.15% | 22,273,217 +4,363,744 | +24% | +$72.6M |
|
131
Las Vegas Sands
LVS
$39.6B
| $370M | 0.15% | 8,704,693 -13,360,711 | -61% | -$567M |
|
132
Chevron
CVX
$324B
| $369M | 0.14% | 5,095,249 -1,364,296 | -21% | -$98.9M |
|
133
Electronic Arts
EA
$43B
| $364M | 0.14% | 3,630,076 +1,567,265 | +76% | +$157M |
|
134
Masco
MAS
$15.4B
| $359M | 0.14% | 10,379,898 -666,590 | -6% | -$23M |
|
135
Salesforce
CRM
$245B
| $351M | 0.14% | 2,436,617 -622,728 | -20% | -$89.7M |
|
136
Williams-Sonoma
WSM
$23.1B
| $351M | 0.14% | 8,250,267 +251,369 | +3% | +$10.7M |
|
137
Consolidated Edison
ED
$35.4B
| $349M | 0.14% | +4,479,059 | New | +$349M |
|
138
Nice
NICE
$8.73B
| $346M | 0.14% | 2,407,557 +71,776 | +3% | +$10.3M |
|
139
Alexandria Real Estate Equities
ARE
$14.1B
| $343M | 0.13% | 2,499,630 +501,073 | +25% | +$68.7M |
|
140
Simon Property Group
SPG
$59B
| $335M | 0.13% | 6,108,783 -3,700,004 | -38% | -$203M |
|
141
Northrop Grumman
NOC
$84.5B
| $334M | 0.13% | 1,102,367 -416,988 | -27% | -$126M |
|
|
TSG
142
DELISTED
The Stars Group Inc.
TSG
| $330M | 0.13% | 16,149,773 +2,728,095 | +20% | +$55.7M |
|
|
GWPH
143
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $325M | 0.13% | 3,707,103 +84,036 | +2% | +$7.36M |
|
144
Western Union
WU
$2.8B
| $314M | 0.12% | 17,294,482 -11,675,046 | -40% | -$212M |
|
|
BLUE
145
DELISTED
bluebird bio
BLUE
| $313M | 0.12% | 6,812,412 +33,279 | +0.5% | +$1.53M |
|
146
Telus
TU
$25.1B
| $302M | 0.12% | 19,079,481 +10,894,628 | +133% | +$172M |
|
147
Vertex Pharmaceuticals
VRTX
$100B
| $298M | 0.12% | 1,250,664 +15 | +0% | +$3.57K |
|
148
Ultragenyx Pharmaceutical
RARE
$2.89B
| $292M | 0.11% | 6,573,960 +211,265 | +3% | +$9.39M |
|
149
Johnson & Johnson
JNJ
$427B
| $289M | 0.11% | 2,207,276 -691,374 | -24% | -$90.7M |
|
150
MongoDB
MDB
$25.7B
| $289M | 0.11% | 2,115,476 +23,201 | +1% | +$3.17M |
|